Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
MiRNA biomarkers of prostate disease
This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing prostate disease in a patient. These miRNA biomarkers may be used alone or in combination with other markers for the diagnosis, prognosis, or monitoring of diseases such as prostate cancer.
Asuragen, Inc.
C C C C
C12Q C12Q C12Q C12Q
additional additional additional inventional
Jeffrey Alex David Stephanie Kevin
Shelton Adai Brown Volz Kelnar